Developing individualized ground testing protocols for use of sleep medications in spaceflight

dc.contributor.advisorSmith L. Johnston MD, MSen_US
dc.contributor.committeeMemberRichard T. Jennings MD, MSen_US
dc.contributor.committeeMemberDaniel H. Freeman Jr. PhDen_US
dc.creatorKalpesh Purohiten_US
dc.date.accessioned2011-12-20T16:04:55Z
dc.date.available2010-09-28en_US
dc.date.available2011-12-20T16:04:55Z
dc.date.created2010-07-11en_US
dc.date.issued2010-05-18en_US
dc.description.abstractDuring spaceflight, sleep time are markedly reduced for astronauts. Sleep medications are used by astronauts during space mission for sleep. Spaceflight is an environment where abrupt alarm awakening is always a possibility and during that time high cognitive function and performance may be needed to prevent loss of life of crew. Zolpidem has been used on spaceflight after ground testing. The medication has been tested and studies have shown few side effects after a complete night of sleep. Few studies have been done on abrupt awakening after taking this medication. This study was done to test the effects of this medication on abrupt awakening after taking this medication and comparing to placebo. Seven subjects were selected and tested over two nights, one night with zolpidem and one night with placebo. Using a randomized single blind crossover design and testing cognitive function using a standard battery of computer based tests. Subjects were abruptly awakened after 2 hours of taking placebo and zolpidem. Subjects were videotaped, wore an actigraph and completed standard tasks and computer based testing bouts. When compared to placebo, on the night subjects were given zolpidem, subjects showed greater delay to alarm shut off, increased lapses of attention, and a large amount of variation between subjects. Actigraphy and video tape data correlated with the results of the computer based testing. Actigraph data also showed that subjects had similar average amounts of sleep with placebo and zolpidem. This study was not a traditional sleep study, it was operational study with practical testing of abrupt awakening and its effect on cognitive function. This study also provides evidence in support of developing a practical, individualized ground-based protocol for evaluating the cognitive performance deficits of sleep medications commonly used in spaceflight by NASA astronauts. The results of this study can be applicable to other fields where fatigue and sleep are an issue (military, shift work, etc). This protocol can also be used to test alertness medications in a similar way.en_US
dc.format.mediumelectronicen_US
dc.identifier.otheretd-07112010-200901en_US
dc.identifier.urihttp://hdl.handle.net/2152.3/156
dc.language.isoengen_US
dc.rightsCopyright © is held by the author. Presentation of this material on the TDL web site by The University of Texas Medical Branch at Galveston was made possible under a limited license grant from the author who has retained all copyrights in the works.en_US
dc.subjectspaceflighten_US
dc.subjectsleep medicationen_US
dc.subjectsleep inertiaen_US
dc.subjectmedications in space flighten_US
dc.subjectground testing medicationsen_US
dc.subjectground testingen_US
dc.subjectabrupt awakeningen_US
dc.titleDeveloping individualized ground testing protocols for use of sleep medications in spaceflighten_US
dc.type.genrethesisen_US
dc.type.materialtexten_US
thesis.degree.departmentPreventive Medicine and Community Healthen_US
thesis.degree.grantorThe University of Texas Medical Branchen_US
thesis.degree.levelMasteren_US
thesis.degree.nameMaster of Public Healthen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CAPSTONE_FINAL_20100711.pdf
Size:
791.33 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
891 B
Format:
Plain Text
Description: